NAGE Q4 2016 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+29.3% YoY

Gross Profit

$2M40.8% margin

Operating Income

-$2M-37.6% margin

Net Income

-$2M-38.0% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+43.3%

Cash Flow

Operating Cash Flow

$191,186

Free Cash Flow

-$387,758

Stock-Based Comp.

$263,756

Balance Sheet

Total Assets

$20M

Total Liabilities

$10M

Stockholders' Equity

$10M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+29.3%
Gross Profit	$2M	$2M	+43.6%
Operating Income	-$2M	-$1M	-71.2%
Net Income	-$2M	-$1M	-50.5%